TRDA EBITDA Growth
Entrada Therapeutics Inc · EBITDA Growth
TRDA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-125.86%period ending
TRDA TTM EBITDA YoY % (-89.77% → -125.86%)
Year-over-year change
High-resolution chart · PNG
TRDA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -125.859% | |
| -697.4922% | |
| -302.683% | |
| -225.461% | |
| -149.1271% | |
| -64.8645% | |
| 41.3841% | |
| 410.5902% | |
| 337.1381% | |
| 206.0968% | |
| 153.5935% | |
| 118.0575% | |
| 17.709% | |
| -17.3571% | |
| -85.4885% | |
| -114.2882% | |
| -128.7852% | |
| -116.8755% | |
| -89.7726% |